AMNEAL PHARMACEUTICALS, INC Long Term Debt 2010-2024 | AMRX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AMNEAL PHARMACEUTICALS, INC long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AMNEAL PHARMACEUTICALS, INC long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.

Related Stocks
Company Name	Market Cap
Chugai Pharmaceutical (CHGCY)	$79.9B
Zoetis (ZTS)	$70.1B
Daiichi Sankyo, - (DSNKY)	$43.9B
Takeda Pharmaceutical (TAK)	$43.7B
Sandoz Group AG (SDZNY)	$20.6B
Merck (MKKGY)	$18.3B
Astellas Pharma (ALPMY)	$17.4B
United Therapeutics (UTHR)	$17B
Summit Therapeutics (SMMT)	$15.9B
Shionogi (SGIOY)	$12.3B
Neurocrine Biosciences (NBIX)	$11.4B
Corcept Therapeutics (CORT)	$7.7B
Madrigal Pharmaceuticals (MDGL)	$7.5B
Orion OYJ (ORINY)	$7.4B
Hikma Pharmaceuticals Plc (HKMPF)	$6.2B
Stevanato Group S.p.A (STVN)	$6.2B
Grifols, S.A (GRFS)	$5.1B
Ionis Pharmaceuticals (IONS)	$5B
Ono Pharmaceutical (OPHLF)	$4.7B
Recursion Pharmaceuticals (RXRX)	$4.2B
Crinetics Pharmaceuticals (CRNX)	$3.4B
Catalyst Pharmaceuticals (CPRX)	$2.7B
Hypermarcas (HYPMY)	$2.2B
Centessa Pharmaceuticals (CNTA)	$2.1B
Soleno Therapeutics (SLNO)	$2B
BioCryst Pharmaceuticals (BCRX)	$1.9B
NewAmsterdam Pharma (NAMS)	$1.8B
Evotec AG (EVO)	$1.6B
Ardelyx (ARDX)	$1.5B
Indivior (INDV)	$1.5B